A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts

Venous thromboembolism (VTE) is a leading cause of death among patients with cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with cancer receiving chemotherapy, but its accuracy in identifying patients at high risk has been questioned. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz, Andrés, Ay, Cihan, Grilz, Ella, López, Sonia, Font, Carme, Pachón, Vanesa, Castellón, Victoria, Martínez-Marín, Virginia, Salgado, Mercedes, Martínez, Eva, Calzas, Julia, Ortega, Laura, Rupérez, Ana, Salas, Eduardo, Pabinger, Ingrid, Soria, Jose Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414737/
https://www.ncbi.nlm.nih.gov/pubmed/36730884
http://dx.doi.org/10.1200/JCO.22.00255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414737/
https://www.ncbi.nlm.nih.gov/pubmed/36730884
http://dx.doi.org/10.1200/JCO.22.00255

Ejemplares similares